Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Can you hear me now? Patient preferences for evaluating kidney transplant centers.

Sawinski D, Locke JE.

Am J Transplant. 2018 Aug 9. doi: 10.1111/ajt.15066. [Epub ahead of print] No abstract available.

PMID:
30091840
2.

Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation.

Shelton BA, Sawinski D, Linas BP, Reese PP, Mustian M, Hungerpiller M, Reed RD, MacLennan PA, Locke JE.

Am J Transplant. 2018 Jul 30. doi: 10.1111/ajt.15040. [Epub ahead of print]

PMID:
30058218
3.

Expand the Pool of Living Donors for Kidney Transplantation.

Locke JE.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1142-1143. doi: 10.2215/CJN.07310618. Epub 2018 Jul 16. No abstract available.

PMID:
30012627
4.

Population Health, Ethnicity and Rate of Living Donor Kidney Transplantation.

Reed RD, Sawinski D, Shelton BA, MacLennan PA, Hanaway M, Kumar V, Long D, Gaston RS, Kilgore ML, Julian BA, Lewis CE, Locke JE.

Transplantation. 2018 May 22. doi: 10.1097/TP.0000000000002286. [Epub ahead of print]

PMID:
29787519
5.

Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-Year Single-Center Experience.

Young CJ, MacLennan PA, Mannon EC, Reed RD, Shelton BA, Hanaway MJ, Agarwal G, Gaston RS, Julian BA, Kew CE 2nd, Kumar V, Mannon RB, Mehta S, Ong SC, Towns GC, Deierhoi MH, Locke JE.

Ann Surg. 2018 May 17. doi: 10.1097/SLA.0000000000002816. [Epub ahead of print]

PMID:
29781845
6.

Response to "It is time to revise the kidney allocation system to restore the pediatric advantage".

Shelton BA, Locke JE.

Am J Transplant. 2018 Sep;18(9):2367. doi: 10.1111/ajt.14934. Epub 2018 Jun 11. No abstract available.

PMID:
29762906
7.

In Reply to 'Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline'.

Sawinski D, Locke JE.

Am J Kidney Dis. 2018 Jul;72(1):155. doi: 10.1053/j.ajkd.2018.02.359. Epub 2018 Apr 16. No abstract available.

PMID:
29673727
8.

Impact of the new kidney allocation system A2/A2B → B policy on access to transplantation among minority candidates.

Martins PN, Mustian MN, MacLennan PA, Ortiz JA, Akoad M, Caicedo JC, Echeverri GJ, Gray SH, Lopez-Soler RI, Gunasekaran G, Kelly B, Mobley CM, Black SM, Esquivel C, Locke JE.

Am J Transplant. 2018 Aug;18(8):1947-1953. doi: 10.1111/ajt.14719. Epub 2018 Mar 31.

PMID:
29509285
9.

Response to: Regarding "HIV protease inhibitors and mortality following kidney transplantation".

Shelton BA, Sawinski D, Locke JE.

Am J Transplant. 2018 Jun;18(6):1571. doi: 10.1111/ajt.14688. Epub 2018 Mar 5. No abstract available.

PMID:
29419939
10.

Evaluation of Kidney Donors: Core Curriculum 2018.

Sawinski D, Locke JE.

Am J Kidney Dis. 2018 May;71(5):737-747. doi: 10.1053/j.ajkd.2017.10.018. Epub 2018 Jan 11.

PMID:
29336856
11.

Decreasing deceased donor transplant rates among children (≤6 years) under the new kidney allocation system.

Shelton BA, Sawinski D, Ray C, Reed RD, MacLennan PA, Blackburn J, Young CJ, Gray S, Yanik M, Massie A, Segev DL, Locke JE.

Am J Transplant. 2018 Jul;18(7):1690-1698. doi: 10.1111/ajt.14663. Epub 2018 Feb 7.

PMID:
29333639
12.

Expanding clarity or confusion? Volatility of the 5-tier ratings assessing quality of transplant centers in the United States.

Schold JD, Andreoni KA, Chandraker AK, Gaston RS, Locke JE, Mathur AK, Pruett TL, Rana A, Ratner LE, Buccini LD.

Am J Transplant. 2018 Jun;18(6):1494-1501. doi: 10.1111/ajt.14659. Epub 2018 Feb 9.

PMID:
29316241
13.

Landscape of ABO-Incompatible Live Donor Kidney Transplantation in the US.

Mustian MN, Cannon RM, MacLennan PA, Reed RD, Shelton BA, McWilliams DM, Deierhoi MH, Locke JE.

J Am Coll Surg. 2018 Apr;226(4):615-621. doi: 10.1016/j.jamcollsurg.2017.12.026. Epub 2018 Jan 5.

PMID:
29309944
14.

Assessing emergency department utilization in the era of population health.

Schold JD, Locke JE.

Am J Transplant. 2018 Apr;18(4):777-778. doi: 10.1111/ajt.14641. Epub 2018 Jan 21. No abstract available.

PMID:
29288620
15.

Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney.

Shelton BA, Sawinski D, Mehta S, Reed RD, MacLennan PA, Locke JE.

Transpl Infect Dis. 2018 Apr;20(2):e12829. doi: 10.1111/tid.12829. Epub 2018 Jan 25.

PMID:
29277956
16.

Apolipoprotein L1 Gene Effects on Kidney Transplantation.

Freedman BI, Locke JE, Reeves-Daniel AM, Julian BA.

Semin Nephrol. 2017 Nov;37(6):530-537. doi: 10.1016/j.semnephrol.2017.07.006. Review.

PMID:
29110760
17.

Race but not Hepatitis C co-infection affects survival of HIV+ individuals on dialysis in contemporary practice.

Sawinski D, Forde KA, Locke JE, Cohen JB, Weldon J, Shults J, Reese PP.

Kidney Int. 2018 Mar;93(3):706-715. doi: 10.1016/j.kint.2017.08.015. Epub 2017 Oct 26.

PMID:
29107361
18.

Expanding the use of hepatitis C-viremic kidney donors.

Sawinski D, Wyatt CM, Locke JE.

Kidney Int. 2017 Nov;92(5):1031-1033. doi: 10.1016/j.kint.2017.09.002.

PMID:
29055420
19.

Urologic malignancies in kidney transplantation.

Hickman LA, Sawinski D, Guzzo T, Locke JE.

Am J Transplant. 2018 Jan;18(1):13-22. doi: 10.1111/ajt.14533. Epub 2017 Dec 1. Review.

PMID:
28985026
20.

Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants.

Chow EK, DiBrito S, Luo X, Wickliffe CE, Massie AB, Locke JE, Gentry SE, Garonzik-Wang J, Segev DL.

Transplantation. 2018 Mar;102(3):471-477. doi: 10.1097/TP.0000000000001957.

PMID:
28938312
21.

Patient and Kidney Allograft Survival in Recipients With End-Stage Renal Disease From Amyloidosis.

Sawinski D, Lim MA, Cohen JB, Locke JE, Weiss B, Hogan JJ, Dember LM.

Transplantation. 2018 Feb;102(2):300-309. doi: 10.1097/TP.0000000000001930.

PMID:
28885498
22.

Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes.

Cohen JB, Eddinger KC, Shelton B, Locke JE, Forde KA, Sawinski D.

Clin Kidney J. 2017 Aug;10(4):564-572. doi: 10.1093/ckj/sfx048. Epub 2017 Jul 11.

23.

Living Kidney Donor Phenotype and Likelihood of Postdonation Follow-up.

Reed RD, Shelton BA, MacLennan PA, Sawinski DL, Locke JE.

Transplantation. 2018 Jan;102(1):135-139. doi: 10.1097/TP.0000000000001881.

PMID:
28787311
24.

PROviding Better ACcess To ORgans: A comprehensive overview of organ-access initiatives from the ASTS PROACTOR Task Force.

Hobeika MJ, Miller CM, Pruett TL, Gifford KA, Locke JE, Cameron AM, Englesbe MJ, Kuhr CS, Magliocca JF, McCune KR, Mekeel KL, Pelletier SJ, Singer AL, Segev DL.

Am J Transplant. 2017 Oct;17(10):2546-2558. doi: 10.1111/ajt.14441. Epub 2017 Sep 2.

PMID:
28742951
25.

Impact of Protease Inhibitor-Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients.

Sawinski D, Shelton BA, Mehta S, Reed RD, MacLennan PA, Gustafson S, Segev DL, Locke JE.

Am J Transplant. 2017 Dec;17(12):3114-3122. doi: 10.1111/ajt.14419. Epub 2017 Aug 24.

PMID:
28696079
26.

Survival Benefit of Transplantation with a Deceased Diabetic Donor Kidney Compared with Remaining on the Waitlist.

Cohen JB, Eddinger KC, Locke JE, Forde KA, Reese PP, Sawinski DL.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):974-982. doi: 10.2215/CJN.10280916. Epub 2017 May 25.

27.

Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors.

Muzaale AD, Althoff KN, Sperati CJ, Abraham AG, Kucirka LM, Massie AB, Kitahata MM, Horberg MA, Justice AC, Fischer MJ, Silverberg MJ, Butt AA, Boswell SL, Rachlis AR, Mayor AM, Gill MJ, Eron JJ, Napravnik S, Drozd DR, Martin JN, Bosch RJ, Durand CM, Locke JE, Moore RD, Lucas GM, Segev DL.

Am J Transplant. 2017 Jul;17(7):1823-1832. doi: 10.1111/ajt.14235. Epub 2017 May 12.

28.

Patterns of primary care utilization before and after living kidney donation.

Alejo JL, Luo X, Massie AB, Henderson ML, DiBrito SR, Locke JE, Purnell TS, Boyarsky BJ, Anjum S, Halpern SE, Segev DL.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12992. Epub 2017 Jun 5.

29.

Quantifying Postdonation Risk of ESRD in Living Kidney Donors.

Massie AB, Muzaale AD, Luo X, Chow EKH, Locke JE, Nguyen AQ, Henderson ML, Snyder JJ, Segev DL.

J Am Soc Nephrol. 2017 Sep;28(9):2749-2755. doi: 10.1681/ASN.2016101084. Epub 2017 Apr 27.

30.

The Authors Reply.

Locke JE, Reed RD, Massie AB, Segev DL.

Kidney Int. 2017 May;91(5):1256. doi: 10.1016/j.kint.2017.02.007. No abstract available.

PMID:
28407878
31.

Access to Kidney Transplantation among HIV-Infected Waitlist Candidates.

Locke JE, Mehta S, Sawinski D, Gustafson S, Shelton BA, Reed RD, MacLennan P, Bolch C, Durand C, Massie A, Mannon RB, Gaston R, Saag M, Overton T, Segev DL.

Clin J Am Soc Nephrol. 2017 Mar 7;12(3):467-475. doi: 10.2215/CJN.07460716. Epub 2017 Feb 23.

32.

Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.

Locke JE, Sawinski D, Reed RD, Shelton B, MacLennan PA, Kumar V, Mehta S, Mannon RB, Gaston R, Julian BA, Carr JJ, Terry JG, Kilgore M, Massie AB, Segev DL, Lewis CE.

Ann Surg. 2018 Jun;267(6):1161-1168. doi: 10.1097/SLA.0000000000002174.

PMID:
28187045
33.

Abdominal lean muscle is associated with lower mortality among kidney waitlist candidates.

Locke JE, Carr JJ, Nair S, Terry JG, Reed RD, Smith GD, Segev DL, Kumar V, Lewis CE.

Clin Transplant. 2017 Mar;31(3). doi: 10.1111/ctr.12911. Epub 2017 Feb 8.

34.

Obesity increases the risk of end-stage renal disease among living kidney donors.

Locke JE, Reed RD, Massie A, MacLennan PA, Sawinski D, Kumar V, Mehta S, Mannon RB, Gaston R, Lewis CE, Segev DL.

Kidney Int. 2017 Mar;91(3):699-703. doi: 10.1016/j.kint.2016.10.014. Epub 2016 Dec 29.

35.

Dosing Eculizumab for Antibody-Mediated Rejection in Kidney Transplantation: A Case Report.

Smith B, Kumar V, Mompoint-Williams D, Reed RD, MacLennan PA, Stegner K, Locke JE.

Transplant Proc. 2016 Nov;48(9):3099-3105. doi: 10.1016/j.transproceed.2016.03.028.

PMID:
27932156
36.

Kidney transplantation of highly sensitized recipients under the new kidney allocation system: A reflection from five different transplant centers across the United States.

Parsons RF, Locke JE, Redfield RR 3rd, Roll GR, Levine MH.

Hum Immunol. 2017 Jan;78(1):30-36. doi: 10.1016/j.humimm.2016.10.009. Epub 2016 Oct 20. Review.

37.

Survival Benefit of Kidney Transplantation in HIV-infected Patients.

Locke JE, Gustafson S, Mehta S, Reed RD, Shelton B, MacLennan PA, Durand C, Snyder J, Salkowski N, Massie A, Sawinski D, Segev DL.

Ann Surg. 2017 Mar;265(3):604-608. doi: 10.1097/SLA.0000000000001761.

38.

Lymphocyte-depleting induction therapy lowers the risk of acute rejection in African American pediatric kidney transplant recipients.

Crowson CN, Reed RD, Shelton BA, MacLennan PA, Locke JE.

Pediatr Transplant. 2017 Feb;21(1). doi: 10.1111/petr.12823. Epub 2016 Oct 3.

PMID:
27699934
39.

Insurance Type and Solid Organ Transplantation Outcomes: A Historical Perspective on How Medicaid Expansion Might Impact Transplantation Outcomes.

DuBay DA, MacLennan PA, Reed RD, Shelton BA, Redden DT, Fouad M, Martin MY, Gray SH, White JA, Eckhoff DE, Locke JE.

J Am Coll Surg. 2016 Oct;223(4):611-620.e4. doi: 10.1016/j.jamcollsurg.2016.07.004. Epub 2016 Jul 25.

40.

Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)-Infected Recipients.

Shelton BA, Mehta S, Sawinski D, Reed RD, MacLennan PA, Gustafson S, Segev DL, Locke JE.

Am J Transplant. 2017 Jan;17(1):173-179. doi: 10.1111/ajt.13922. Epub 2016 Jul 19.

41.

Inpatient Mortality Among Solid Organ Transplant Recipients Hospitalized for Sepsis and Severe Sepsis.

Donnelly JP, Locke JE, MacLennan PA, McGwin G Jr, Mannon RB, Safford MM, Baddley JW, Muntner P, Wang HE.

Clin Infect Dis. 2016 Jul 15;63(2):186-94. doi: 10.1093/cid/ciw295. Epub 2016 May 23.

42.

Identification of Optimal Donor-Recipient Combinations Among Human Immunodeficiency Virus (HIV)-Positive Kidney Transplant Recipients.

Locke JE, Shelton BA, Reed RD, MacLennan PA, Mehta S, Sawinski D, Segev DL.

Am J Transplant. 2016 Aug;16(8):2377-83. doi: 10.1111/ajt.13847. Epub 2016 Jun 15.

43.

Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus.

Kucirka LM, Durand CM, Bae S, Avery RK, Locke JE, Orandi BJ, McAdams-DeMarco M, Grams ME, Segev DL.

Am J Transplant. 2016 Aug;16(8):2368-76. doi: 10.1111/ajt.13840. Epub 2016 May 25.

44.

Anti-Blood Group Antibodies in Intravenous Immunoglobulin May Complicate Interpretation of Antibody Titers in ABO-Incompatible Transplantation.

Staley EM, Carruba SS, Manning M, Pham HP, Williams LA 3rd, Marques MB, Locke JE, Lorenz RG.

Am J Transplant. 2016 Aug;16(8):2483-6. doi: 10.1111/ajt.13760. Epub 2016 Mar 17.

45.

Hospital-onset Clostridium difficile infection among solid organ transplant recipients.

Donnelly JP, Wang HE, Locke JE, Mannon RB, Safford MM, Baddley JW.

Am J Transplant. 2015 Nov;15(11):2970-7. doi: 10.1111/ajt.13491.

46.

A systematic review of the use of expandable cages in the cervical spine.

Elder BD, Lo SF, Kosztowski TA, Goodwin CR, Lina IA, Locke JE, Witham TF.

Neurosurg Rev. 2016 Jan;39(1):1-11; discussion 11. doi: 10.1007/s10143-015-0649-8. Epub 2015 Jul 28. Review.

PMID:
26212700
47.

Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.

Locke JE, Durand C, Reed RD, MacLennan PA, Mehta S, Massie A, Nellore A, DuBay D, Segev DL.

Transplantation. 2016 Jan;100(1):141-6. doi: 10.1097/TP.0000000000000829.

48.

The biomechanics of pedicle screw augmentation with cement.

Elder BD, Lo SF, Holmes C, Goodwin CR, Kosztowski TA, Lina IA, Locke JE, Witham TF.

Spine J. 2015 Jun 1;15(6):1432-45. doi: 10.1016/j.spinee.2015.03.016. Epub 2015 Mar 20. Review.

PMID:
25797809
49.

A systematic assessment of the use of platelet-rich plasma in spinal fusion.

Elder BD, Holmes C, Goodwin CR, Lo SF, Puvanesarajah V, Kosztowski TA, Locke JE, Witham TF.

Ann Biomed Eng. 2015 May;43(5):1057-70. doi: 10.1007/s10439-015-1300-0. Epub 2015 Mar 21. Review.

PMID:
25794962
50.

A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients.

Locke JE, Mehta S, Reed RD, MacLennan P, Massie A, Nellore A, Durand C, Segev DL.

J Am Soc Nephrol. 2015 Sep;26(9):2222-9. doi: 10.1681/ASN.2014070726. Epub 2015 Mar 19.

Supplemental Content

Loading ...
Support Center